Skip to main content
Premium Trial:

Request an Annual Quote

What Happens When You Can't Count Single Genes?

A column in the New York Times talks about the impact of recent scientific findings that make it more likely that the old one gene, one protein concept is falling by the wayside -- including the recent ENCODE publications showing that genes are not as discrete and separated as previously thought. For one thing, what about those patents covering genes, if the concept of a gene is overruled? Writer Denise Caruso predicts that there will be sweeping ramifications for the entire biotech industry.


The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.